Clinical Trial Update: Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and early efficacy signals of combining abemaciclib with darolutamide in men with metastatic prostate cancer that progress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)
• Darolutamide (darolutamide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Prostatic Neoplasms | Phase 1 | Status: COMPLETED